NYBC Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
24
- Portfolio
-
14
- Exits
-
4
NYBC Ventures General Information
Company Description
Founded in 2022, NYBC Ventures is the corporate venture capital arm of New York Blood Center, based in Boston, Massachusetts. The firm prefers to invest in early-stage companies operating in the cell therapy, transfusion medicine, benign hematology, and infectious disease sectors, of which emerging technologies, including in-vivo cell therapy, gene editing, iPSC, and regenerative medicine, are of interest.
Business Details
Website
www.nybcventures.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 420 Boylston Street
- Suite 501
- Boston, MA 02116
- United States
NYBC Ventures Investments (24)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Star Therapeutics | 23-Oct-2026 | Later Stage VC | Biotechnology | Generating Revenue | ||
| City Therapeutics | 04-Jun-2026 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Vitestro | 02-Mar-2026 | Diagnostic Equipment | Generating Revenue | |||
| Lightning Biotherapeutics | 01-Mar-2026 | Biotechnology | Stealth | |||
| TTP | 09-Jan-2026 | Consulting Services (B2B) | Generating Revenue | |||
| Veralox Therapeutics | 23-Sep-2025 | Drug Discovery | Generating Revenue | |||
| Star Therapeutics | 22-Sep-2025 | Biotechnology | Generating Revenue | |||
| AvenCell | 11-Sep-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Akadeum Life Sciences | 25-Apr-2025 | Later Stage VC | Discovery Tools (Healthcare) | Generating Revenue | ||
| Immusoft | 15-Mar-2025 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 1 |
NYBC Ventures Exits (4)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| City Therapeutics | 15-Oct-2026 | IPO | |
| Vega Therapeutics | 06-Jul-2026 | ||
| Thymmune | 02-Jul-2026 | Merger/Acquisition | |
| Veralox Therapeutics | 01-Jan-2026 | Secondary Transaction - Private |
NYBC Ventures Investments by Industry, Year, and Region
NYBC Ventures Co-Investors (83)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Agent Capital | 2 |
|
|
||
| Michigan Capital Network |
|
|
|||
| Sanofi Ventures |
|
|
|||
| Sofinnova Investments |
|
|
|||
| Viking Global Investors |
|
|
NYBC Ventures Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Blood Bank of Delmarva | Newark, DE | 1954 |
NYBC Ventures FAQs
-
What is NYBC Ventures?
Founded in 2022, NYBC Ventures is the corporate venture capital arm of New York Blood Center, based in Boston, Massachusetts.
-
When was NYBC Ventures founded?
NYBC Ventures was founded in 2022.
-
Where is NYBC Ventures headquartered?
NYBC Ventures is headquartered in Boston, MA.
-
What is NYBC Ventures's total asset value?
NYBC Ventures has around in total assets under management.
-
How many investments has NYBC Ventures made?
NYBC Ventures has made 24 investments.
-
What has NYBC Ventures invested in?
NYBC Ventures has made numerous investments in companies like Star Therapeutics, City Therapeutics, and Vitestro within the Biotechnology, Drug Discovery, and Diagnostic Equipment industries.
-
What has NYBC Ventures invested in recently?
NYBC Ventures's latest investment was on 23-Oct-2026 in Star Therapeutics, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process